Klinikum Mutterhaus der Borromaeerinnen

Trier 54290

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Breast Cancer With Low to Intermediate HER2 Expression

Studies at this site

• Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence — Completed
• A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer — Completed